Literature DB >> 33754630

HLA class I allele-lacking leukocytes predict rare clonal evolution to MDS/AML in patients with acquired aplastic anemia.

Kohei Hosokawa1, Hiroki Mizumaki1, Takeshi Yoroidaka1, Hiroyuki Maruyama1, Tatsuya Imi1, Noriaki Tsuji1, Ryota Urushihara1, Mikoto Tanabe1, Yoshitaka Zaimoku1, Mai Anh Thi Nguyen1, Dung Cao Tran1, Ken Ishiyama1, Hirohito Yamazaki2, Takamasa Katagiri3, Hiroyuki Takamatsu1, Kazuyoshi Hosomichi4, Atsushi Tajima4, Fumihiro Azuma5, Seishi Ogawa6, Shinji Nakao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33754630     DOI： 10.1182/blood.2020010586

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.

Authors:  Emma M Groarke; Bhavisha A Patel; Ruba Shalhoub; Fernanda Gutierrez-Rodrigues; Parth Desai; Harshraj Leuva; Yoshitaka Zaimoku; Casey Paton; Nina Spitofsky; Jennifer Lotter; Olga Rios; Richard W Childs; David J Young; Alina Dulau-Florea; Cynthia E Dunbar; Katherine R Calvo; Colin O Wu; Neal S Young
Journal:  Leukemia       Date:  2022-07-27       Impact factor: 12.883

2.  Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.

Authors:  Noriaki Tsuji; Kohei Hosokawa; Ryota Urushihara; Mikoto Tanabe; Takamasa Katagiri; Tatsuhiko Ozawa; Hiroyuki Takamatsu; Ken Ishiyama; Hirohito Yamazaki; Hiroyuki Kishi; Seishi Ogawa; Shinji Nakao
Journal:  Leukemia       Date:  2022-04-26       Impact factor: 12.883

3.  Molecular landscape of immune pressure and escape in aplastic anemia.

Authors:  Simona Pagliuca; Carmelo Gurnari; Colin Hercus; Sébastien Hergalant; Niroshan Nadarajah; Adam Wahida; Laila Terkawi; Minako Mori; Weiyin Zhou; Valeria Visconte; Stephen Spellman; Shahinaz M Gadalla; Caiying Zhu; Ping Zhu; Torsten Haferlach; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2022-10-17       Impact factor: 12.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.